2,4-pentanedione

2,4-pentanedione is a lipid of Fatty Acyls (FA) class. The related lipids are Butyrates.

Cross Reference

Introduction

To understand associated biological information of 2,4-pentanedione, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,4-pentanedione

MeSH term MeSH ID Detail
Purpura, Thrombocytopenic D011696 2 associated lipids
Per page 10 20 | Total 11

PubChem Associated disorders and diseases

What pathways are associated with 2,4-pentanedione

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What functions are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What lipids are associated with 2,4-pentanedione?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,4-pentanedione

Download all related citations
Per page 10 20 50 100 | Total 1027
Authors Title Published Journal PubMed Link
Iakovidis I et al. Copper and its complexes in medicine: a biochemical approach. 2011 Mol Biol Int pmid:22091409
Zhao Y et al. (1E,4Z,6E)-5-Hy-droxy-1,7-bis-(2-meth-oxy-phen-yl)-1,4,6-hepta-trien-3-one. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:22090937
Ahmad R et al. 3-Acetyl-5-hy-droxy-2-methyl-anthra[1,2-b]furan-6,11-dione. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21754452
Wang FM (Acetyl-acetonato-κO,O')(2-bromo-4-chloro-6-{[2-(dimethyl-amino)-ethyl-imino]-meth-yl}phenolato-κN,N',O)oxidovanadium(IV). 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21754355
Kumar M et al. Zinc complexes of Ttz(R,Me) with O and S donors reveal differences between Tp and Ttz ligands: acid stability and binding to H or an additional metal (Ttz(R,Me) = tris(3-R-5-methyl-1,2,4-triazolyl)borate; R = Ph, tBu). 2011 Dalton Trans pmid:21706096
Gasser G et al. Organometallic anticancer compounds. 2011 J. Med. Chem. pmid:21077686
Singh DP et al. Spectroscopic studies and antibacterial activities of some new 16-membered octaazamacrocyclic complexes derived from thiocarbohydrazide and pentane-2,4-dione. 2011 Spectrochim Acta A Mol Biomol Spectrosc pmid:21208826
Jacobsen JA et al. Identifying chelators for metalloprotein inhibitors using a fragment-based approach. 2011 J. Med. Chem. pmid:21189019
Rashad AE et al. Studies on the reactivity of (9-Methyl-5,6-dihydronaphtho[1â,2â:4,5]-thieno[2,3-d]pyrimidin-11-yl)hydrazine towards some reagents for biological evaluation. 2010 Jan-Mar Sci Pharm pmid:21179366
Lodhia J et al. Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI. 2010 Apr-Jun Biomed Imaging Interv J pmid:21611034